Search
for
Sort by
Research
60-90 / 1000+ results
research B/N-doped carbon nano-onions as nanocarriers for targeted breast cancer therapy
This study reports that a new boron/nitrogen-doped carbon nano-onion-based delivery system for doxorubicin enhanced its uptake and anticancer effects in specific cancer cell types, while reducing cardiotoxicity in human heart cells.
research Dermoscopic evaluation of efficacy of 308 nm Excimer Laser in treatment of alopecia areata: A prospective study
This study evaluated the effect of 308 nm excimer laser on alopecia areata, reporting that among 34 patches treated, 13% showed excellent response and 67% demonstrated moderate to good response, as assessed by dermoscopic indicators of disease remission and regrowth.
research Effect of diode pumping solid state laser with wavelength 589 nm on gene expression of interlukine-2 and interferon-gamma Lowercase in human T-lymphocytes
In this experimental study, laser irradiation significantly altered the gene expression of cytokines in cultured human T-cell lymphocytes, suggesting that such laser light may photobiomodulate cytokine production in vitro.
research The Effectiveness of 675 nm Wavelength Laser Therapy in the treatment Androgenetic alopecia among Indian patients. (Preprint)
In this study, 14 sessions of 675 nm laser stimulation significantly improved hair count, density, and thickness in Indian patients with androgenetic alopecia, with an increase of around 17% in hair parameters over four months.
research Higher percentage of CD34+ stem cells and elevated efficacy in androgenetic alopecia treatment observed in CGF prepared from 640 nm laser‐pretreated blood: A preliminary study
This study found that pretreating concentrated growth factor with a 640 nm laser increased CD34+ stem cell activation and improved hair growth outcomes in androgenetic alopecia patients compared to non-pretreated CGF.
research Investigator‐blinded, controlled, and randomized comparative study on 1565 nm non‐ablative fractional laser versus 5% minoxidil for treatment of androgenetic alopecia
This study reported that the 1565 nm non-ablative fractional laser treatment significantly improved various hair growth indices in patients with androgenetic alopecia compared to 5% minoxidil, demonstrating its superior clinical efficacy and safety for treating this condition.
research Novel Application of 1064-nm Picosecond Nd:YAG Laser for Male Androgenetic Alopecia Treatment.
In this pilot study, researchers found that fractional picosecond laser therapy may promote hair regrowth in men with mild-to-moderate androgenetic alopecia, with significant improvements in expert assessments and patient satisfaction observed over a four-month period, though further research is needed to confirm these findings.
research Treatment of erythromelanosis follicularis faciei et colli with a 595‐nm pulsed dye laser
This report describes three cases of erythromelanosis follicularis faciei et colli showing significant improvement in facial telangiectasia following treatment with a 595-nm pulsed dye laser, with minimal recurrence observed during follow-up.
research Efficacy and Safety of Combination 308-nm Excimer Laser and Intralesional Corticosteroid versus Intralesional Corticosteroid Monotherapy in the Treatment of Frontal Fibrosing Alopecia: A Pilot Study
In this study, the researchers found no superiority of combining 308-nm excimer laser with intralesional corticosteroid over corticosteroid alone for treating frontal fibrosing alopecia, and reported side effects such as erythema and postinflammatory hyperpigmentation in both treatment groups.
research The 675 nm laser for the treatment of facial acne scars in dark skin type
This study evaluated the effectiveness of a 675 nm laser device on facial acne scars in patients with darker skin types, finding that 67% reported excellent improvement and 33% reported good improvement, with significant enhancements in skin texture and appearance after five treatments.
research Successful management of severe alopecia areata and vitiligo using topical delgocitinib and a 308-nm excimer laser
This study reported that therapeutic make-up significantly improves the long-term quality of life for patients with facial dermatoses, showing a sustained benefit one year after application, particularly in younger patients.
research Photobiomodulation With a Continuous Wave Red Laser (660 nm) as Monotherapy for Adult Alopecia Areata: A Case Presentation
This case report describes the first use of photobiomodulation therapy with a continuous wave red laser (660 nm) as monotherapy for alopecia areata, resulting in significant hair regrowth within 7 days, though further research is needed for conclusive evidence.
research Experience of Novelty Laser Therapy Emission with 675 nm Wavelength for the Treatment of Androgenetic Alopecia in Male and Female Patients: A Case Series Study
In this study, 675 nm laser treatment significantly improved hair density and reduced miniaturization in both male and female patients with alopecia androgenetica, showing promising results without side effects after 10 sessions.
research Safer 1064 nm long-pulse frequency settings and safety eyewear setup to improve visualization of superficial veins
This letter discusses findings from an article by Sun et al. showing that neodymium doped yttrium aluminum garnet laser effectively treats prominent facial vasculature in patients with frontal fibrosing alopecia, but highlights concerns about the risk of iatrogenic scarring and suggests caution with treatment frequency.
research 604 Comparison of 1064-nm Nd:YAG picosecond lasers using fractional micro-lens array vs. ablative fractional 2940-nm Er:YAG lasers for the treatment of atrophic acne scar in Asians: A 20-week prospective, randomized, split-face, controlled trial
In this study, Nd:YAG picosecond lasers using fractional micro-lens array were found to have a comparable effect to ablative fractional Er:YAG lasers in treating atrophic acne scars, with better safety profiles but slightly less patient satisfaction.
research The 532 Nm Laser Treatment Promotes the Proliferation of Tendon- Derived Stem Cells and Up-Regulates Nr4a1 to Stimulate Tenogenic Differentiation
This study found that a 532 nm laser at 15 J/cm² enhanced the proliferation and differentiation of tendon-derived stem cells in rats, potentially accelerating tendon healing through the up-regulation of Nr4a1.
research New 4,800W, 810 nm Diode Laser with a Spot Size of 20x15 mm for Permanent Hair Removal: Pilot Clinical Study
This study evaluated a new high-power, 810 nm diode laser for hair removal, finding it to be effective and safe, with a mean hair reduction of 74.4% in one session, and noted it worked efficiently on both large and small areas with minimal side effects.
research Evaluation of the Efficacy of Excimer Light 308 nm Wavelength Versus Low Level Laser in Treatment of Alopecia Areata
In this study, both excimer light and low level light therapy were found to be safe and effective for treating alopecia areata, with excimer light showing better and more sustained improvement.
research Expression of collagen type I, skin fibroblasts and macrophages after 1550 nm erbium glass fractional laser in androgenic alopecia
In this study, collagen type I, skin fibroblasts, and macrophages did not show remarkable changes in androgenic alopecia patients' scalp tissues after treatment with 1550 nm fractional Er:Glass laser, despite improved hair regrowth.
research The effect of 1540?nm fractional erbium?glass laser in the treatment of androgenic alopecia
The 1540nm fractional erbium-glass laser helps treat hair loss caused by hormones.
research A prospective, comparative evaluation of axillary hair removal with an 808-nm diode laser at different fluences
This study evaluated an 808-nm diode laser at different fluences for permanent axillary hair removal in Korean women and found that high-fluence treatment (14 J/cm2) effectively reduced hair density and thickness, with no significant difference in comfort compared to lower fluences.
research Alopecia Totalis Treated with 1064 nm Picosecond Nd:YAG Laser: A Case Report
This case report suggests that 1064 nm picosecond Nd:YAG laser therapy may effectively improve alopecia totalis when used as an alternative adjuvant treatment, as demonstrated in a split-scalp study showing better results than steroid treatment alone.
research Molluscum Contagiosum Infection After 1927-nm Nonablative Fractional Laser Treatment
This article describes the Dermatologic Surgery journal, which publishes comprehensive, peer-reviewed information on cosmetic and reconstructive skin surgery, but offers no new research findings.
research Targeting nonmelanoma skin cancer using selective photothermolysis with 595 nm pulsed dye laser: Outcomes of 1080 cases
595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.
research Original papers A study on efficacy of 308 nm excimer light therapy in alopecia areata
This study evaluated 308 nm excimer light therapy for alopecia areata but the abstract does not provide specific clinical results or conclusions.
research Q-switched Nd:YAG 1064-nm laser for the treatment of acne-induced postinflammatory hyperpigmentation
Fractional infrared technology is effective and safe for treating cervical laxity.
research Evaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic Alopecia
This study observed that both PRP and 1550 nm fractional erbium-glass laser improved AGA, with greater hair density in patients receiving the combination therapy and no side effects reported.
research Alterations of collagen type 1, skin fibroblasts, and macrophages in the scalp following the treatment of 1550‐nm erbium glass fractional laser for androgenetic alopecia
Laser treatment shows promise for hair growth, but needs further research.
research Successful Treatment of Scalp Micropigmentation With 1064 nm Picosecond Nd:YAG Laser
In this study, using a 1064 nm picosecond Nd:YAG laser effectively removed undesirable scalp micropigmentation in four patients within 1–3 treatment sessions, with no unexpected adverse events reported.